Literature DB >> 32852026

Cisplatin binding to β-lactoglobulin: a structural study.

Nicole Balasco1, Giarita Ferraro, Domenico Loreto, Ilaria Iacobucci, Maria Monti, Antonello Merlino.   

Abstract

β-Lactoglobulin is a major globular milk whey carrier with potential applications as an oral drug delivery system. Herein, the interactions between β-lactoglobulin and cisplatin are investigated by UV-Vis absorption spectroscopy, circular dichroism, X-ray crystallography and electrospray ionization mass spectrometry. Structural data indicate that the protein retains its conformation upon cisplatin binding. Pt-containing fragments bind the side chains of Met7, His146 and Lys8, with the number of binding sites increasing over time. Mass spectrometry data indicate that [Pt(NH3)2Cl+], [Pt(NH3)2OH22+] and [Pt(NH3)22+] fragments interact with β-lactoglobulin; up to 3 cisplatin fragments can bind the protein and the number of cisplatin binding sites increases over time. This work opens a new pathway in pharmaceutical studies based on a rational design of metal-based drug/β-lactoglobulin adducts as delivering vehicles of metallodrugs.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32852026     DOI: 10.1039/d0dt02582h

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  3 in total

1.  Current and emerging mass spectrometry methods for the preclinical development of metal-based drugs: a critical appraisal.

Authors:  Maciej Jarosz; Bernhard K Keppler; Andrei R Timerbaev
Journal:  Anal Bioanal Chem       Date:  2021-10-12       Impact factor: 4.142

2.  New ligand-binding sites identified in the crystal structures of β-lactoglobulin complexes with desipramine.

Authors:  Joanna I Loch; Jakub Barciszewski; Joanna Śliwiak; Piotr Bonarek; Paulina Wróbel; Kinga Pokrywka; Ivan G Shabalin; Wladek Minor; Mariusz Jaskolski; Krzysztof Lewiński
Journal:  IUCrJ       Date:  2022-04-29       Impact factor: 5.588

3.  Protein-Based Delivery Systems for Anticancer Metallodrugs: Structure and Biological Activity of the Oxaliplatin/β-Lactoglobulin Adduct.

Authors:  Daria Maria Monti; Domenico Loreto; Ilaria Iacobucci; Giarita Ferraro; Alessandro Pratesi; Luigi D'Elia; Maria Monti; Antonello Merlino
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.